Reappraisal of role of angiotensin receptor blockers in cardiovascular protection

Angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) have shown cardioprotective and renoprotective properties. These agents are recommended as first-line therapy for the treatment of hypertension and the reduction of cardiovascular risk. Early studies pointed to...

Descripción completa

Detalles Bibliográficos
Autor principal: Ram, C Venkata S
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2011
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3104608/
https://www.ncbi.nlm.nih.gov/pubmed/21633521
http://dx.doi.org/10.2147/VHRM.S15787

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3104608/
https://www.ncbi.nlm.nih.gov/pubmed/21633521
http://dx.doi.org/10.2147/VHRM.S15787

Ejemplares similares